• Citer

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel

par Arboleda, Bolivar;Bartsch, Rupert;de Azambuja, Evandro ;Hamilton, Erika;Harbeck, Nadia;Klemp, Jennifer;Knauer, Michael;Kuemmel, Sherko;Mahtani, Reshma;Schwartzberg, Lee L.S.;Villarreal-Garza, Cynthia;Wolff, Antonio C
Référence The oncologist, 27, 9, page (722-731)
Publication Publié, 2022-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel
Auteur:	Arboleda, Bolivar; Bartsch, Rupert; de Azambuja, Evandro; Hamilton, Erika; Harbeck, Nadia; Klemp, Jennifer; Knauer, Michael; Kuemmel, Sherko; Mahtani, Reshma; Schwartzberg, Lee L.S.; Villarreal-Garza, Cynthia; Wolff, Antonio C
Informations sur la publication:	The oncologist, 27, 9, page (722-731)
Statut de publication:	Publié, 2022-09
Sujet CREF:	Cancérologie
Mots-clés:	adjuvant chemotherapy
	early breast cancer
	genomic testing
	MINDACT
	ovarian function suppression
	premenopausal
	TAILORx
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1549-490X
	info:doi/10.1093/oncolo/oyac101
	info:scp/85137169740
	info:pmid/35704278